Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1999 | 1 |
2000 | 1 |
2001 | 1 |
2008 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Showing results for
hedrick ee[au]
Your search for
Hetrick EE[au]
retrieved no results
Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.
J Clin Oncol. 2008 Jan 10;26(2):183-9. doi: 10.1200/JCO.2007.13.8099.
J Clin Oncol. 2008.
PMID: 18182660
High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis.
Kewalramani T, Zelenetz AD, Hedrick EE, Donnelly GB, Hunte S, Priovolos AC, Qin J, Lyons NC, Yahalom J, Nimer SD, Moskowitz CH.
Kewalramani T, et al. Among authors: hedrick ee.
Blood. 2000 Oct 1;96(7):2399-404.
Blood. 2000.
PMID: 11001890
Free article.
Item in Clipboard
Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma.
Moskowitz CH, Bertino JR, Glassman JR, Hedrick EE, Hunte S, Coady-Lyons N, Agus DB, Goy A, Jurcic J, Noy A, O'Brien J, Portlock CS, Straus DS, Childs B, Frank R, Yahalom J, Filippa D, Louie D, Nimer SD, Zelenetz AD.
Moskowitz CH, et al. Among authors: hedrick ee.
J Clin Oncol. 1999 Dec;17(12):3776-85. doi: 10.1200/JCO.1999.17.12.3776.
J Clin Oncol. 1999.
PMID: 10577849
Clinical Trial.
Item in Clipboard
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.
Moskowitz CH, Nimer SD, Zelenetz AD, Trippett T, Hedrick EE, Filippa DA, Louie D, Gonzales M, Walits J, Coady-Lyons N, Qin J, Frank R, Bertino JR, Goy A, Noy A, O'Brien JP, Straus D, Portlock CS, Yahalom J.
Moskowitz CH, et al. Among authors: hedrick ee.
Blood. 2001 Feb 1;97(3):616-23. doi: 10.1182/blood.v97.3.616.
Blood. 2001.
PMID: 11157476
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite